R&D Systems™ Recombinant Human Flt-3 Ligand/FLT3L Protein

Catalog No.	Quantity	Formulation
308FKN025CF	25 μg	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
308FKN005CF	5 μg	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
308FKN005	5 μg	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
308FKN025	25 μg	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.

Catalog No. 308FKN025CF Supplier R&D Systems™ Supplier No. 308FKN025/CF

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured in a cell proliferation assay using BaF3 mouse pro-B cells transfected with mouse Flt-3. The ED50 for this effect is 0.2-1 ng/mL.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Gene ID (Entrez): 2323
• Molecular Weight (g/mol): 18 kDa
• Name: Flt-3 Ligand
• Quantity: 25 μg
• Source: Mouse myeloma cell line,NS0-derived human Flt-3 Ligand/FLT3L protein Thr27-Pro185
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: FL, FLG3L, Flt3 ligand, Flt3L, FLT3LG, fms-related tyrosine kinase 3 ligand, SL cytokine
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute 5 μg vials at 50 μg/mL in sterile PBS. Reconstitute 25 μg or larger vials at 100-250 μg/mL in sterile PBS.
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.